MeSH term | MeSH ID | Detail |
---|---|---|
Airway Obstruction | D000402 | 13 associated lipids |
Virodhamine is a lipid of Fatty Acyls (FA) class. Virodhamine is associated with abnormalities such as abnormal fragmented structure. The involved functions are known as Ionization, Diastasis, GTP Binding, Mass-to-Charge Ratio and esterase activity. Virodhamine often locates in Body tissue, Plasma membrane and Skin. The related lipids are Arachidonic Acid, AM 404, methanandamide and Fatty Acids.
To understand associated biological information of virodhamine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
virodhamine is suspected in and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with virodhamine
MeSH term | MeSH ID | Detail |
---|---|---|
Airway Obstruction | D000402 | 13 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Brantl SA et al. | Activation of platelets by the endocannabinoids 2-arachidonoylglycerol and virodhamine is mediated by their conversion to arachidonic acid and thromboxane A2, not by activation of cannabinoid receptors. | 2014 | Platelets | pmid:24102401 |
Brantl SA et al. | Mechanism of platelet activation induced by endocannabinoids in blood and plasma. | 2014 | Platelets | pmid:23789792 |
Dudášová A et al. | The effects of cannabidiol on the antigen-induced contraction of airways smooth muscle in the guinea-pig. | 2013 | Pulm Pharmacol Ther | pmid:23428645 |
Rogers TJ | The molecular basis for neuroimmune receptor signaling. | 2012 | J Neuroimmune Pharmacol | pmid:22935971 |
Sharir H et al. | The endocannabinoids anandamide and virodhamine modulate the activity of the candidate cannabinoid receptor GPR55. | 2012 | J Neuroimmune Pharmacol | pmid:22454039 |
Gkoumassi E et al. | (Endo)cannabinoids mediate different Ca2+ entry mechanisms in human bronchial epithelial cells. | 2009 | Naunyn Schmiedebergs Arch. Pharmacol. | pmid:19255745 |
Ozalp A and Barroso B | Simultaneous quantitative analysis of N-acylethanolamides in clinical samples. | 2009 | Anal. Biochem. | pmid:19665986 |
Kozłowska H et al. | Virodhamine relaxes the human pulmonary artery through the endothelial cannabinoid receptor and indirectly through a COX product. | 2008 | Br. J. Pharmacol. | pmid:18806815 |
Hayase T | Nicotine (NC)-induced "depressive" behavioral symptoms and effects of antidepressants including cannabinoids (CBs). | 2008 | J Toxicol Sci | pmid:19043277 |
Lam PM et al. | Ultra performance liquid chromatography tandem mass spectrometry method for the measurement of anandamide in human plasma. | 2008 | Anal. Biochem. | pmid:18555789 |